Literature DB >> 15080847

Systemic review: Natural history of irritable bowel syndrome.

H B El-Serag1, P Pilgrim, P Schoenfeld.   

Abstract

BACKGROUND: The natural history of irritable bowel syndrome is unclear, including the likelihood that these patients will be diagnosed with an alternative organic or functional gastrointestinal disorder. Understanding the stability of an irritable bowel syndrome diagnosis may limit repeated diagnostic evaluation among these patients.
METHODS: The inclusion criteria included observational longitudinal studies of clinic-based samples of adult patients with irritable bowel syndrome. Only studies published in the English language in full manuscript form were included. Literature searches, selection and review of eligible articles, and data abstraction were performed in a duplicate, independent manner.
RESULTS: Fourteen studies met study selection criteria. In six studies with relevant information, 2-5% of irritable bowel syndrome patients were diagnosed with an alternative organic GI disorder after 6 months to 6 years of follow-up. Long-term follow-up indicated that 2-18% of patients developed worse irritable bowel syndrome symptoms, approximately 30-50% of patients had unchanged symptoms, and the rest either improved or had symptoms disappear. Prior surgery (one study), higher somatic scores (one study), higher baseline anxiety (two studies), depression scores (one study) were predictive of worsening of symptoms during long-term follow-up.
CONCLUSIONS: Irritable bowel syndrome, a chronic disorder, is a stable diagnosis. Once initial investigations are negative, fewer than 5% are diagnosed with an alternative organic GI disorder. Repeated diagnostic evaluations of patients with recurrent or persistent symptoms similar to their baseline symptoms are not warranted.

Entities:  

Mesh:

Year:  2004        PMID: 15080847     DOI: 10.1111/j.1365-2036.2004.01929.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  20 in total

Review 1.  Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations?

Authors:  Laura Noddin; Michael Callahan; Brian E Lacy
Journal:  MedGenMed       Date:  2005-08-29

Review 2.  Common Functional Gastroenterological Disorders Associated With Abdominal Pain.

Authors:  Adil E Bharucha; Subhankar Chakraborty; Christopher D Sletten
Journal:  Mayo Clin Proc       Date:  2016-08       Impact factor: 7.616

Review 3.  Functional diarrhea.

Authors:  Michael J G Farthing
Journal:  Curr Gastroenterol Rep       Date:  2005-10

4.  Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Dabo Xu; Vincent L Chen; Calen A Steiner; Jeffrey A Berinstein; Shanti Eswaran; Akbar K Waljee; Peter D R Higgins; Chung Owyang
Journal:  Am J Gastroenterol       Date:  2019-07       Impact factor: 10.864

5.  What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea?

Authors:  Darren C R Fernandes; Dennis Poon; Laura L White; H Jervoise N Andreyev
Journal:  Frontline Gastroenterol       Date:  2018-07-26

6.  Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: an observational cohort prospective study.

Authors:  Antonina A Mikocka-Walus; Deborah A Turnbull; Nicole T Moulding; Ian G Wilson; Gerald J Holtmann; Jane M Andrews
Journal:  Biopsychosoc Med       Date:  2008-06-06

7.  Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls.

Authors:  D Lundgren; J Rutegård; V Eklöf; R Palmqvist; P Karling
Journal:  BMC Gastroenterol       Date:  2016-11-24       Impact factor: 3.067

8.  Exploring the agreement between diagnostic criteria for IBS in primary care in Greece.

Authors:  Foteini Anastasiou; Ioannis A Mouzas; Joanna Moschandreas; Elias Kouroumalis; Christos Lionis
Journal:  BMC Res Notes       Date:  2008-12-03

9.  Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trial.

Authors:  Liang Zheng; Weimin Lu; Qi Xiao; Yaoliang Lai; Heng Fan; Yuling Sun; Dawei Huang; Yuanyuan Wang; Zhen Li; Zhengyan Jiang; Xingxing Liu; Lijuan Zhang; Dongmei Zuo; Zhexing Shou; Qing Tang; Huisuo Huang; Yongqiang Yang; Zongxiang Tang; Jun Xiao
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

Review 10.  Long-term efficacy and safety of otilonium bromide in the management of irritable bowel syndrome: a literature review.

Authors:  John K Triantafillidis; George Malgarinos
Journal:  Clin Exp Gastroenterol       Date:  2014-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.